Sophia Genetics: Peter Casasanto, Abhi Verma
Jan 10, 2022
Sophia Genetics has hired Peter Casasanto as chief biopharma officer and Abhimanyu (Abhi) Verma as chief technology officer. Casasanto, who has more than 15 years of experience in life sciences business development and sales, comes to Sophia after serving as VP of new commercialization initiatives for Canadian precision medicine laboratory services provider CellCarta. Verma previously had several leadership positions at Novartis, covering applied technology innovation, real-world evidence, drug development, enterprise technologies, IT strategy, data science, and artificial intelligence.